bupropion


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to bupropion: Wellbutrin, bupropion hydrochloride

bupropion

 [bu-pro´pe-on]
a compound structurally similar to amphetamine, used in the form of the hydrochloride salt as an antidepressant and as an aid in smoking cessation to reduce the symptoms of nicotine withdrawal; administered orally.

bupropion

/bu·pro·pi·on/ (bu-pro´pe-on) a monocyclic compound structurally similar to amphetamine, used as the hydrochloride salt as an antidepressant and as an aid in smoking cessation.

bupropion

(byo͞o-prō′pē-ŏn′)
n.
A drug, C13H18ClNO, used in its hydrochloride form for the treatment of depression and as an aid in smoking cessation. It is a weak inhibitor of norepinephrine and dopamine reuptake in the central nervous system.

buPROPion

[boo͡prō′pē·on]
a heterocyclic mood-elevating drug used to treat some types of depression (trademark: Wellbutrin) and also to promote smoking cessation (trademark: Zyban).

bupropion

Zyban® Psychiatry An antidepressant Side effects Dry mouth, insomnia Contraindications Seizures, bulimia

bupropion

A drug used in the treatment of tobacco, drug and alcohol dependency. Bupropion reacts adversely with a wide range of other drugs and may induce seizures in sensitive persons. When used, a strict regime is necessary. A brand name is Zyban.

Bupropion

An antidepressant medication given to smokers for nicotine withdrawal symptoms. It is sold under the trade name Zyban.

bupropion (byōō´prō´pēon),

n brand names: Wellbutrin, Zyban;
drug class: antidepressant;
action: weak uptake inhibitor of dopamine, serotonin, norepinephrine; mechanism unknown;
uses: treatment of depression and anxiety disorders; tobacco cessation.
References in periodicals archive ?
Nonclinical studies suggest that naltrexone and bupropion have effects on two separate areas of the brain involved in the regulation of food intake: the hypothalamus (appetite regulatory center) and the mesolimbic dopamine circuit (reward system).
Findings also indicate that, when compared with bupropion, only varenicline reduced the psychological reward, or pleasure, derived from smoking, when measured among those who Initially lapsed, while trying to retain abstinence during the program.
Dr Habil Khorakiwala, Founder Chairman and Group CEO, Wockhardt added, This is our sixth ANDA approval in past two weeks and Bupropion SR 12-Hr is yet another product based on extended-release technology.
Participants were randomly assigned to the standard therapeutic dose of bupropion (150 mg/day for the first 3 days, followed by 300 mg/day) administered orally for a total of 8 weeks (n = 20) or an identical appearing placebo tablet added to their usual medication regimen (n = 20).
In July, the FDA ordered a black box warning for varenicline and bupropion, urging prescribers to watch for the development of hostility, agitation, depression, and suicidality.
Although the use of bupropion indicated a slightly better quit rate at the end of treatment, the numbers were virtually the same after two years.
Bupropion - sold as Zyban and Wellbutrin SR - has emerged as a front- line treatment since receiving approval as a smoking cessation aid by the Food and Drug Administration in 1997.
Should not be given to patients already taking Welibutrin or Wellbutrin SR, as these also contain bupropion.
Small doses of nicotine delivered through a skin patch, an inhaler, or chewing gum (nicotine replacement therapy, or NRT) can be used alone or in combination with Zyban, the prescription drug bupropion (also sold as an antidepressant, as Wellbutrin).
These generic Bupropion Hydrochloride Extended Release tablets are equivalent to GlaxoSmithKline's Wellbutrin SR[R] Extended Release tablets and includes three strengths: 100 mg, 150 mg and 200 mg.
Contrave (naltrexone HCI and bupropion HCI extended-release), approved by the United States Food and Drug Administration in September 2014, is indicated for use as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m[sup.
Nasdaq: OREX) today announced that the European Commission has granted marketing authorization for Mysimba(TM) (naltrexone HCl / bupropion HCl prolonged release) as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients ([greater than or equal to]18 years) with an initial Body Mass Index (BMI) of[greater than or equal to] 30 kg/m[sup.